Taking a long-term view, we fully expect China's eventual emergence as a full-fledged R&D hub in any global network. Capabilities in chemistry and clinical research are already well established with great potential for rapid growth in biology and preclinical development.

Everyone agrees it's better if it looks better than worse. But near a house it will have a direct and appreciable effect. If you put a sound barrier up, it will have a huge impact on the desirability of a house. If it's a mall, which is busy and has lots of traffic, the impact is proportionally small.

The decision how and when to invest in R&D in China is a strategic choice. By investing more heavily and in more complex areas of R&D in China, an MPC can signal its commitment to the Chinese market and strengthen relationships with key opinion leaders and officials there -- thus increasing its chances of thriving in the health care market now taking shape in China.

Medical insurance should become very attractive to middle-class families in China because they really don't want to undertake that risk themselves.

The prices of any vehicles ordered based on the old price but not yet delivered would be adjusted according to the new prices that will be announced later.